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© 2009 The Japan Society of Histochemistry and Cy- Wnt signaling is important in many aspects of cell biology and development. In the mouse
female reproductive tract, Wnt4, Wnt5a, and Wnt7a show differential expression during the
estrus cycle, suggesting that they participate in female reproductive physiology. Although the
pituitary is a major gland regulating reproduction, the molecular mechanism of Wnt signaling
here is unclear. We elucidated the subcellular distribution of Wnt4 in the pituitary of estro-
gen-treated ovariectomized female rats. Expression of Wnt4 mRNA increased dramatically,
particularly in proestrus compared with estrus and metestrus. Wnt4 protein was observed in
the cytoplasm of almost all growth hormone (GH)-producing cells and in only a few thyroid-
stimulating hormone β (TSHβ)-producing cells. In rat GH-producing pituitary tumor (MtT/S)
cells, estrogen-induced expression of Wnt4 mRNA was completely inhibited by estrogen
receptor antagonist ICI 182,780 in vitro. Thus, rat pituitary GH cells synthesize Wnt4 and
this is induced by estrogen mediated via an estrogen receptor alpha-dependent pathway.
Key words: Wnt signaling, pituitary gland, estrogen, estrus cycle, growth hormone
I. Introduction
Estrogens play various roles in the mammalian pitu-
itary gland, affecting prolactin (PRL) and gonadotropin gene
transcription, and are involved in lactotroph cell growth,
which regulates the estrus cycle [35]. The biological actions
of estrogens are mediated by binding to one of two specific
estrogen receptors (ERs), ERα or ERβ, belonging to the nu-
clear receptor superfamily [24, 31]. ERα is highly expressed
in the pituitary, ovary, uterus, testis, prostate, epididymis,
kidney, and adrenal gland [21]. ERβ is highly expressed in
the reproductive organs such as the rat ovary and prostate,
but moderate expression is expressed in numerous other
tissues including the testis and uterus, some of which also
express ERα [20, 21]. ERα and ERβ can be dimerized
in several forms such as ERα/ERα, ERα/ERβ, and
ERβ/ERβ, which are able to bind to estrogen responsive
elements (EREs) in the promoter region of various genes [5].
However, the physiological relevance of this ERα/ERβ
interaction remains unclear [32].
The Wnt proteins are important regulators of the Wnt
signaling pathway and have diverse roles in governing cell
fate, proliferation, migration, polarity, and cell death [2].
The Wnt genes encode a family of 38–45 kDa secreted
cysteine-rich proteins that lack transmembrane domains
and are modified by N-linked glycosylation. The secreted
Wnt proteins associate with extracellular matrix proteins
on or near the cell surface and thus can exert autocrine or
paracrine effects [17]. Frizzled (Fzd) proteins are recep-
tors for the Wnt ligands, which resemble typical G protein
coupled receptors [28]. Wnt signaling includes three differ-
ent pathways: (i) the canonical Wnt/β-catenin pathway; (ii)
the noncanonical Wnt/JNK pathway, involving regulationMiyakoshi et al. 206
of tissue polarity and cell movement through the activation
of RhoA, c-Jun N-terminal kinase (JNK), and nemo-like
kinase (NLK) signaling cascades; and (iii) the noncanoni-
cal Wnt/Ca2+ pathway, involving activation of calcium/
calmodulin-dependent kinase II (CamKII) and protein
kinase C (PKC) [14, 16, 17, 19].
One member of the Wnt family of genes, Wnt4, is a
growth factor that is known to be involved in multiple devel-
opmental processes, such as the formation of the kidney,
adrenal gland, and mammary gland [13, 18, 39, 42, 43].
In the pituitary gland Wnt4−/− mutant mice repress the dif-
ferentiation of growth hormone (GH)-, thyroid stimulating
hormone (TSH)β- and glycoprotein hormone alpha-subunit
(αGSU)-producing cells, and pituitary-specific positive
transcription factor 1 (Pit-1)-positive cells during the em-
bryonic stage [33, 41]. In human pituitary adenomas, we
have previously shown that Wnt4 is highly expressed in
GHomas, PRLomas, and TSHomas, all of which belong to
the Pit-1 cell lineage of anterior pituitary cells [30]. Wnt5a
is expressed at all stages of mammary development except
during lactation and is required for posterior growth of the
female reproductive tract [9, 25]. Wnt7a directly regulates
the prenatal growth of the female reproductive tract and
maintains proper uterine function in the adult mouse [26].
Wnt4, Wnt5a, and Wnt7a are expressed at high levels in
the mouse female reproductive tract [27]. In particular, these
Wnts have been reported to show differential expression
during the estrus cycle in the murine uterus and the mam-
mary gland and have been implicated as having important
roles in the female reproductive system [27, 38]. The pitu-
itary gland is a major gland that regulates the reproductive
system, but the regulatory mechanism of Wnt signaling is
unclear. These observations led us to investigate the role
of estrogen in modulating the expression and molecular
functions of Wnts including Wnt4, Wnt5a, and Wnt7a
in the rat pituitary gland.
II. Materials and Methods
Animals and vaginal smears
Female 7-week-old Sprague Dawley rats were pur-
chased from Charles River Japan, Inc. (Kanagawa, Japan).
They were housed under a 12/12 hr light/dark cycle (lights
on at 08:00 hr) at 22±2°C room temperature, with access to
rat chow and tap water ad libitum. Animal usage and all pro-
cedures were approved by the Tokai University Institutional
Animal Care and Use Committee. The estrus cycles of the
animals were monitored through daily examination of vagi-
nal cytology [34]. Rats were selected for experiments after
exhibiting at least two normal 4-day estrus cycles.
Ovariectomy
After acclimation, the rats were divided into three
groups  using  a  randomized  complete  block  design,
as follows: sham-operated and treated with sesame oil
(Sham+vehicle); ovariectomized treated with sesame oil
(OVX+vehicle) and ovariectomized treated with estrogen
(OVX+E2). Ovaries were removed while the rats were
under Nembutal anesthesia (50 mg/kg, i.p.) at random stages
of the estrus cycle. All animals were housed individually
after surgery. The estrus cycle was checked daily by examin-
ing vaginal smears between 09:00 and 10:00 hr. Four weeks
after sham operation or OVX, the animals received an intra-
muscular injection of estradiol dipropionate (E2, 300 mg/kg,
Aska Pharmaceutical Co., Ltd., Tokyo, Japan) or sesame oil
every other day for three doses. The rats were euthanized
with ether 48 hr after the last treatment.
Cell culture and treatment
Rat somatotrophic pituitary tumor (MtT/S) cell lines
(kindly provided by Professor Kinji Inoue, Saitama Univer-
sity, Saitama, Japan) were cultured in Dulbecco’s modified
Eagle’s medium (DMEM)/F-12 (4.5 g/L glucose; Gibco
BRL, Grand Island, NY, USA) supplemented with 10%
horse serum (Bio Whittaker Inc., Walkersville, MD, USA),
2.5% fetal bovine serum (Gibco BRL) and 100 U/L penicil-
lin/streptomycin (Gibco BRL) under an atmosphere of 5%
CO2 and 95% air at 37°C. For estrogen time course studies,
when cells reached about 70% confluency they were cul-
tured in phenol red-free DMEM/F-12 supplemented with
10% dextran-charcoal-treated fetal bovine serum for 2 d.
The MtT/S cells were seeded into 6-well plates at a density
of 5×105 cells/well and cultured with 10−9 M of 17β-estradiol
(Wako Pure Chemicals Industries, Ltd., Osaka, Japan)
at 37°C for 2, 6 or 10 hr. For estrogen receptor antagonist
studies, cells were grown as described above, 10−9 M of
17β-estradiol was added alone or with 10−8 M to 10−6 M
of ICI 182,780 (Tocris Bioscience, Ellisville, MO, USA)
at 37°C for 2 hr. Control cultures were exposed to medium
containing 0.1% dimethyl sulfoxide (DMSO).
Real-time reverse transcription polymerase chain reaction 
(RT-PCR)
Total cellular RNA was isolated using the SV Total
RNA Isolation System (Promega, Madison, WI, USA) sup-
plemented with RNase-free DNase I, according to the
manufacturer’s recommended protocol. One milligram of
total RNA was converted to double-stranded cDNA using
QuantiTect Reverse Transcription Kit (Qiagen, Valencia,
CA, USA). For ERα and ERβ mRNA expression levels,
PCR amplifications were performed as follows: 10 min at
94°C; followed by 30 cycles consisting of 30 sec at 94°C,
30 sec at 60°C and 30 sec at 72°C and then a final 10 min
extension at 72°C. The PCR products were separated by
electrophoresis on 2.0% agarose gels and detected under UV
illumination. Quantification of Wnt4 and Wnt5a mRNA ex-
pression levels were done using real-time RT-PCR using a
reaction mixture containing SYBR Green fluorescent dye
(DyNAmo SYBR Green qPCR kit; Finnzymes, Espoo, Fin-
land). Real-time RT-PCR analysis was done using a DNA
Opticon system (MJ Research, Waltham, MA, USA). Prim-
ers used for PCR are summarized in Table 1. PCR primers
were designed using Primer3 software (http://primer3.
sourceforge.net/). The levels of Wnt4 and Wnt5a mRNAExpression of Wnt4 in Rat GH Cells 207
expression were normalized relative to that of the Gapdh
gene. The reaction protocol consisted of the following
cycles: 95°C for 10 min, 40 cycles of 94°C for 10 sec,
60°C for 15 sec and 72°C for 15 sec, followed by 72°C
for 5 min. All PCR reactions were performed in triplicates.
Immunohistochemistry
Pituitary glands were dissected out and fixed in ice-
cold 4% paraformaldehyde in phosphate buffered saline
(PBS) overnight at 4°C. The fixed tissues were dehydrated
and embedded in paraffin wax using standard procedures.
Tissue sections approximately 5 μm thick were deparaf-
finized in xylene and rehydrated in ethanol. The slides were
then heated in an autoclave for 15 min in a Target Retrieval
Solution (DAKO, Carpinteria, CA, USA) and cooled to
room temperature for 20 min. Endogenous peroxidase activ-
ity was blocked with 0.3% hydrogen peroxide in methanol
for 30 min. For double immunostaining of Wnt4 and hor-
mones, the sections were incubated with goat anti-Wnt4
antibody (×400, ab15699; Abcam, Cambridge, UK). After
overnight incubation at 4°C, polyclonal antibodies were
labeled with biotinylated anti-goat IgG antibody (Vector
Laboratories, Burlingame, CA, USA) followed by staining
with streptavidin-Alexa Fluor 488 conjugate (Invitrogen,
Carlsbad, CA, USA). Dual fluorescence labeling was then
tested on the same section with an rabbit anti-GH anti-
body (National Hormone and Pituitary Program; NIDDK,
Torrance, CA, USA) (dilution ×750), rabbit anti-PRL
antibody (NIDDK) (×2000), rabbit anti-TSHβ antibody
(NIDDK) (×2000), rabbit anti-ACTH antibody (NIDDK)
(×1600), rabbit anti-LHβ antibody (NIDDK) (×500) and
rabbit anti-αGSU antibody (NIDDK) (×800) overnight at
4°C. After washing in PBS, sections were incubated over-
night with Alexa Fluor 594-labeled goat anti-rabbit IgG
antibodies (Invitrogen). Finally, sections were mounted
with TOTO-3 (Invitrogen) in 1,4-diazabicyclo[2.2.2]octane
(DABCO; Sigma-Aldrich, St Louis, MO, USA). To exam-
ine colocalization of Wnt4 positive and hormone positive
cells, sections were scanned using a confocal laser scanning
microscope (LSM510META; Carl Zeiss, Jena, Germany).
For double immunostaining of ERα and GH or TSHβ, the
sections were incubated with anti-ERα antibody (×50, 1D5;
DAKO). After overnight incubation at 4°C, the signal was
amplified with DAKO ENVISION+ Kit (DAKO) according
to the manufacture’s recommendations. Immunoreactivity
was visualized by incubation with 3,3'-diaminobenzidine
tetrahydrochloride. After thorough washing in PBS, the
slides were subsequently incubated with rabbit anti-GH
antibody (NIDDK) (×750) or rabbit anti-TSHβ antibody
(NIDDK) (×2000) for 1 hr at room temperature. After
washing in PBS, the slides were incubated with goat anti-
rabbit IgG antibody conjugated with alkaline phosphatase
(DAKO) followed by visualization with 5-bromo-4-chloro-
3-indolyl phosphate and nitroblue tetrazolium chloride
(BCIP/NBT; DAKO).
Absorption testing
Absorption tests on the rat normal pituitary gland were
performed to confirm the specificity for Wnt4 commercial
antibody. For the absorption test, Wnt4 antibody (2.5
μg/mL) was incubated with the blocking peptide (ab23258;
Abcam: 0.004, 0.02, 0.1, 0.5 μg/mL, respectively) at 4°C
overnight; then the complex was centrifuged and the super-
natant was passed through a 0.45-μm filter before incubation.
Statistical analysis
Statistical analysis was performed using a one-way
ANOVA with Tukey’s multiple comparison test by Stat-
Mate III software (ATMS, Tokyo, Japan) and P<0.05 was
assumed significant.
III. Results
Absorption testing
The specificity for Wnt4 was confirmed by an absorp-
tion test using a rat normal pituitary gland. Immunoreactivi-
ty was considerably decreased by the absorption (Fig. 1).
Colocalization of Wnt4 with pituitary hormones in pituitary 
glands of sham-operated rats
Colocalizations of Wnt4 and pituitary hormones were
detected by double immunofluorescence staining in pituitary
glands (Fig. 2). Wnt4 proteins were expressed in almost all
GH-producing cells and in only a few of TSHβ-producing
cells, whereas no other hormone-producing cells expressed
Wnt4.
Colocalization of ERα with GH- or TSHβ-producing cells in 
pituitary glands of sham-operated rats
Colocalizations of ERα with GH- or TSHβ-producing
Table 1. Primer sequences used for RT-PCR
Gene Forward (5'–3') Reverse (5'–3') Product size (bp)
Wnt4 CTGGAGAAGTGTGGCTGTGA GGACTGTGAGAAGGCTACGC 108
Wnt5a TGGCCACATTTTTCTCCTTC GCAGAGAGGCTGTGCTCCTA 119
Wnt7a CCCGAACCCTCATGAACTTA TGTGGTCCAGCACGTCTTAG 125
ERα CATCGATAAGAACCGGAGGA CATCTCTCTGACGCTTGTGC 134
ERβ TTCCCGGCAGCACCAGTAACC TCCCTCTTTGCGTTTGGACTA 262
Gapdh ATGACTCTACCCACGGCAAG TACTCAGCACCAGCATCACC 136Miyakoshi et al. 208
Fig. 1. Absorption testing. One-milliliter aliquots of anti-Wnt4 antibody solution (2.5 μg/mL) were reacted with (A) 0 μg, (B) 0.004 μg,
(C) 0.02 μg, (D) 0.1 μg or (E) 0.5 μg of synthetic Wnt4 peptide (Abcam) and then the reacted solution was applied to sections of rat normal
pituitary gland. Original magnification ×400; Bar=100 μm. Note the dose-dependent decrease in staining by absorption.
Fig. 2. Colocalization of Wnt4 with pitu-
itary hormones in pituitary glands of
sham-operated rats. Expression of Wnt4
and pituitary hormones shown by double
immunofluorescence staining with confo-
cal microscopy, stained for Wnt4 (green)
and (A) GH (red), (B) TSHβ, (C) PRL,
(D) ACTH, (E) LHβ or (F) αGSU. Nuclei
were stained with TOTO-3 (blue). Wnt4
was expressed in almost all growth hor-
mone (GH)-producing cells, while only a
few of Wnt4-positive cells were also
expressed in thyroid stimulating hormone
(TSH)β-producing cells (see arrow).
Original magnification ×630; Bar=20 μm.Expression of Wnt4 in Rat GH Cells 209
cells were detected by immunohistochemical staining in
pituitary glands. ERα proteins were expressed in both
GH- and TSHβ-producing cells (Fig. 3).
Effects of estrogen on Wnt4 and Wnt5a mRNA expression 
levels in rat pituitary glands
First, we analyzed the expression levels of the Wnt4,
Wnt5a and Wnt7a mRNA in the anterior pituitary gland by
RT-PCR. Only the expression of Wnt7a mRNA was not
detected (data not shown). Therefore, we examined the
effects of estrogen on the expression of Wnt4 and Wnt5a
mRNA in rat pituitary by real-time PCR. Treatments of
OVX rats with estrogen produced a 16-fold increase in
Wnt4 mRNA expression compared with OVX+vehicle
group (Fig. 4A) and these results were further supported
by immunocytochemistry (Fig. 4B). Wnt5a mRNA expres-
sion levels were 3.3-fold decreased by treatment of OVX
rats with estrogen in comparison with the OVX+vehicle
group (Fig. 4C).
Wnt4 and Wnt5a mRNA levels during the estrus cycle
Based on the above data, we determined whether the
levels of Wnt4 and Wnt5a mRNA expression differed in the
rat pituitary at four stages of the estrus cycle, proestrus,
estrus, metestrus and diestrus, using real-time RT-PCR.
As expected, Wnt4 mRNA levels were significantly higher
during proestrus than during estrus and metestrus (Fig. 5A).
Wnt5a mRNA levels were significantly higher during
metestrus than during proestrus (Fig. 5B). As also shown
in Figure 5C, a significant elevation of plasma estrogen
level in mature rats has been reported in the proestrus state
[36, 37].
Time-dependent effect of E2 on Wnt4 mRNA expression in rat 
somatotrophic pituitary tumor (MtT/S) cells
To study the effects of estrogens on the expression of
Wnt4 mRNA in rat pure somatotrophic MtT/S cells, they
were treated with E2 at 10−9 M for 2 hr, 6 hr and 10 hr.
Figure 6 shows that after E2 treatment for 2 hr, there was a
significant increase in Wnt4 mRNA expression (P<0.05).
The pure ER antagonist ICI 182,780 reverses the effects of E2 
on the expression of Wnt4 mRNA in MtT/S cells
If estrogen induces Wnt4 expression in an ERα- or
ERβ-dependent manner, blocking these receptors should
Fig. 3. Colocalization of estrogen receptor alpha (ERα) with GH- or
TSHβ-producing cells in pituitary glands of sham-operated rats.
Expression of ERα and (A) GH- and (B) TSHβ-producing cells
shown by double immunohistochemical staining, stained for ERα
(brown) and GH- and TSHβ-producing cells (blue).
Fig. 4. Effect of estrogen on Wnt4 and Wnt5a mRNA expression
levels in rat pituitary glands. Expression levels of (A) Wnt4 and (C)
Wnt5a mRNA in 4-weeks ovariectomized rats injected with estro-
gen for 7 d were measured by real-time reverse transcription poly-
merase chain reaction (RT-PCR), then normalized to Gapdh as an
internal standard. Data are expressed as fold changes from the
sham-operated control group. Each value represents the mean±SD
of six animals per group. *P<0.01, **P<0.001. (B) Expression of
Wnt4 protein was analyzed by immunohistochemical staining.
Original magnification ×400. Bar=100 μm.Miyakoshi et al. 210
affect Wnt4 expression after treatment with ICI 182,780
(Fig. 7). MtT/S cells were treated with 10−9 M E2 alone or in
the presence of 10−8 M to 10−6 M ICI 182,780 for 2 hr. E2
treatment increased Wnt4 mRNA levels compared with
controls, while treatment of ICI 182,780 dose-dependently
decreased  Wnt4 mRNA expressions compared with E2
treatment alone (P<0.001).
Detection of ERα and ERβ mRNA in MtT/S cells
ERα and ERβ mRNA levels in MtT/S cells were
measured by RT-PCR. MtT/S cells did not express ERβ
mRNA but only ERα mRNA (Fig. 8). PCR products of ERα,
ERβ and Gapdh were detected at 134, 262 and 136 bp,
respectively.
Fig. 5. Wnt4 and Wnt5a mRNA levels during the estrus cycle.
Expression levels of (A) Wnt4 and (B) Wnt5a mRNA in pituitary in
the different stages of estrus cycle were measured by real-time RT-
PCR, then normalized to Gapdh as an internal standard. Data are
expressed as fold change from proestrus. Each value represents the
mean±SD of eight animals per group. *P<0.01, **P<0.001. (C)
The concentration of plasma estrogen in Sprague Dawley rats peaks
in proestrus [36, 37].
Fig. 6. Time-dependent effect of E2 on Wnt4 mRNA expression in
rat somatotrophic pituitary tumor (MtT/S) cells. Cells were treated
with E2 at 10−9 M for 2, 6 and 10 hr. Expression levels of Wnt4
mRNA in MtT/S cells were measured by real-time RT-PCR, then
normalized to Gapdh as an internal standard. Each value represents
the mean±SD of three per group. *P<0.05.
Fig. 7. The pure ER antagonist ICI 182,780 reverses the effects of
E2 on the expression of Wnt4 mRNA in MtT/S cells. Cells were
incubated with 10−9 M E2 and/or 10−8 M to 10−6 M ICI 182,780 for
2 hr. Expression levels of Wnt4 mRNA in MtT/S cells were
measured by real-time RT-PCR, then normalized to Gapdh as an
internal standard. Data are expressed as fold changes from vehicle
control. Each value represents the mean±SD of seven per group.
*P<0.001.Expression of Wnt4 in Rat GH Cells 211
IV. Discussion
In this study, we showed that estrogen directly upregu-
lates Wnt4 gene expression in almost all GH-producing cells
in the rat pituitary in an ER-dependent manner, but in only a
few of the TSHβ-producing cells. Wnt4 mRNA expression
level peaked in response to estrogen stimulation during
proestrus, because the concentration of plasma estrogen in
rats is highest at this stage [36, 37]. Previous reports have
been shown that Wnt4 and Wnt5a gene expression levels are
regulated by estrogen in the mouse uterine epithelium [12,
15]. However, we obtained different results in the anterior
pituitary gland, where the expression of Wnt5a mRNA was
downregulated by estrogen treatment and was not dramati-
cally changed during the estrus cycle. Interestingly, previous
studies have shown that Wnt-5a misexpression delays chon-
drocyte maturation, while Wnt-4 misexpression accelerates
both chondrocyte and perichondrium maturation. Thus,
these Wnts have opposing effects on the differentiation of
chondrocytes [11].
It has been suggested that Wnt proteins are associated
with the extracellular matrix and can interact with neighbor-
ing cells [17]. Therefore, this character of Wnts permits us
to speculate that Wnt4 exerts autocrine/paracrine effects.
Although Wnt signaling pathways are determined by the
interaction between Wnt ligand and the Fzd receptor, de-
tailed investigations are limited. Lyons et al. reported that
Wnt4 showed interaction with the CRD on the N terminus
of Fzd6 in MDCK cells [23]. Wnt4 activates both canonical
and noncanonical Wnt signaling pathways, while FZD6
functions as a negative regulator of canonical Wnt signaling
[10]. We have shown that Fzd6 in the normal human pitui-
tary gland is expressed in gonadotrophs [30]. However, we
could not analyze the presence of Fzd6 in the rat pituitary
gland by immunohistochemistry because no antibodies
against rat Fzd6 proteins are available for working with
paraffin-embedded tissues. The signaling pathways of Wnt4
in the rat pituitary gland remain to be investigated further.
The function of Wnt4 in the mature pituitary gland is
unknown. In the mouse mammary gland during pregnancy,
the expression of Wnt4 is increased by progesterone, which
also induces arborization and hypertrophy of the mammary
ducts [1]. Wnt4 also shows differential expression patterns
during the estrus cycle in the murine mammary gland and
the uterus [12, 27, 38]. These results have led to speculation
that the pituitary Wnt4 might be involved in the control of
reproduction related to the estrus cycle as well as in the uter-
us and mammary gland. On the other hand, Wnt4−/− mutant
mice show a dramatic decrease in the number of GH-,
TSHβ-,  αGSU-producing cells and Pit-1-positive cells
during the embryonic stage [33, 41]. In human pituitary
adenomas, Wnt4 protein is highly expressed in GHomas,
PRLomas and TSHomas, all of which belong to the Pit-1
cell lineage of anterior pituitary cells [30]. Pit-1 is essential
for differentiation and expansion of GH-, PRL- and TSH-
producing cells [3, 7, 22, 29]. Therefore, as another func-
tion in the pituitary, Wnt4 might regulate cell proliferation
and differentiation in Pit-1 cell linage.
Hou et al. have shown that estrogen rapidly induces
Wnt4 expression in the murine uterus in an ER-independent
manner [12]. Therefore, to analyze whether the induction of
Wnt-4 by estrogen is a direct effect of ER-independent ac-
tion on pituitary GH cells, we treated GH-producing MtT/S
cells in culture with estrogen alone or in combination with
ICI 182,780 (Fig. 7). In contrast to previous reports, Wnt4
expression was inhibited by ICI 182,780 treatment. Besides,
MtT/S cells do not express ERβ but only ERα. Our results
indicate that Wnt4 expression by estrogen is mediated via an
ERα-dependent pathway in pituitary GH cells.
We have shown that ERα is critical for Wnt4 mRNA
expression in GH-producing cells. Although ERα was
expressed in GH-producing cells, PRL-producing cells and
TSHβ-producing cells belonging to the Pit-1 cell lineage,
Wnt4 was not expressed in PRL-producing cells. This differ-
ential expression of Wnt4 among these cells might be related
to the epigenetic control mechanism of Wnt4 genes in PRL-
producing cells. Recently, Elston et al. have reported that
Wnt inhibitory factor 1 (WIF1) was significantly decreased
in pituitary adenomas by methylation at the CpG island of
WIF-1 promoter [8]. Interestingly, we have found (un-
published observations) a CpG island on the immediate
promoter of Wnt4 using Methyl Primer Express® software
(Applied Biosystems, Foster City, CA, USA). Thus, un-
expressed Wnt4 in PRL-producing cells might result from
methylation of this CpG island of the Wnt4 promoter, but
further investigations are required.
Here we found that the Wnt4 protein was localized to
almost all GH-producing cells. It is conceivable that estro-
gen induced Wnt4 secretion from these cells. Estrogen in-
creases the percentage of GH mRNA and pituitary GH cells
Fig. 8. Detection of ERα and ERβ mRNA expression in MtT/S cells
by RT-PCR analysis. Lane 1, normal rat anterior pituitary gland
(positive control); lane 2, MtT/S cells; lane 3, no template cDNA
(negative control). Top panel: ERα expression was detected as a
134 bp fragment. Middle panel: ERβ expression was detected as a
262 bp fragment. Bottom panel: Gapdh expression was detected as
a 136 bp fragment. All products were amplified for 30 cycles.Miyakoshi et al. 212
in female rats during diestrus and also increases GH mRNA
transcription and GH release through ER-dependent path-
way in rat pituitary GH3 cells [4, 6]. In contrast to increases
in GH cells, estrogen exerts a rapid apoptotic response
through membrane-associated ERs in lactotropes and soma-
totropes [44]. Thus, the expression of Wnt4 is one of the di-
verse effects of estrogen on GH-producing cells. Further-
more, we also found that Wnt4 was expressed in a small
number of TSHβ-producing cells, primarily localized in the
perinuclear region. Subcellular localization of Wnt4 protein
in TSH-producing cells is obviously different from GH-
producing cells. In the endoplasmic reticulum, Wnt3a
is modified by the addition of the mono-unsaturated fatty
acid, palmitoleic acid, at Ser209, which is required for
transport to the Golgi apparatus for Wnt3a secretion [40].
Therefore, we speculated that failure of lipid modifica-
tion in TSH-producing cells leads to retention of Wnt4
in the endoplasmic reticulum. Wnt4 expression in TSH-
producing cells might not be important physiologically in
the pituitary gland.
The precise mechanism(s) by which estrogen induces
Wnt4 gene expression is not known at present. In general,
estrogen is known to mediate transcription through specific
sequences called EREs. Therefore, we speculate that EREs
exist in the 5'-flanking region of the Wnt4 gene. The pro-
moter sequence of Wnt4 does not contain consensus EREs;
however, one putative ERE was found in the Wnt4 im-
mediate promoter within 1.2 kb of the major transcription
start site, using Match-1.0 Public website (http://www.
gene-regulation.com/) (unpublished observations). Accord-
ingly, Wnt4 upregulation by estrogen may be an ER/ERE-
dependent pathway, but further investigations are required.
In conclusion, we have demonstrated that the expres-
sion of Wnt4 in pituitary GH cells is directly regulated by es-
trogen, which is mediated in an ERα-dependent manner.
Thus, Wnt4 might play an important role in pituitary repro-
ductive physiology related to the control of the estrus cycle.
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